The DOI matches its Crossref record.
Dapagliflozin and Atkins Diet in a patient with type 2 Diabetes Mellitus: A combination that should be avoided
Abstract
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
To date, few cases have been reported of euDKA associated with SGLT2 inhibitor use and ketogenic diets in patients with T2DM.
“To date, few cases have been reported of euDKA associated with SGLT2 inhibitor use and ketogenic diets in patients with T2DM.”
From Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature (2021) · cites this paper as [17]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Mistry, S., & Eschler, D. C. (2021) · AACE Clinical Case Reports · doi:10.1016/j.aace.2020.11.009 · Cited by 46
Euglycaemic ketoacidosis from an SGLT 2 inhibitor exacerbated by a ketogenic diet
Sinha, S., Gavaghan, D., & Yew, S. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50434 · Cited by 6
Important Dietary Considerations for Sodium-Glucose Cotransporter 2 Inhibitors
Anthamatten, A. (2023) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2022.104527
Metadata
- Authors
- Grammatiki, M., Rapti, E., Dina, D., Koufakis, T., Antonopoulou, V., Tsekmekidou, X., Yavropoulou, M., Karras, S., Zebekakis, P., & Kotsa, K.
- ORCID
- Venue
- Endocrine Abstracts
- Publisher
- Bioscientifica
- Published
- 2018-05-08
- ISSN
- 1470-3947 (ISSN-L)
- 1479-6848
- OpenAlex
- W2803280456
- Cited by
- 3
- References
- 0
- Citations by year
- 2023: 1 · 2020: 1 · 2019: 1
- Type
- conference abstract
- Language
- en
- Open access
- closed
- Locations
- Endocrine Abstracts (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- dapagliflozin, Atkins diet, type 2 diabetes, SGLT2 inhibitors, dietary ketosis, food-drug interactions, adverse drug reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
